Lieschke GJ - Search Results

1

Mice lacking both macrophage- and granulocyte-macrophage colony-stimulating factor have macrophages and coexistent osteopetrosis and severe lung disease.

Lieschke GJ, Stanley E, Grail D, Hodgson G, Sinickas V, Gall JA, Sinclair RA, Dunn AR. Lieschke GJ, et al. Blood. 1994 Jul 1;84(1):27-35. Blood. 1994. PMID: 8018921 Free article.

2

Studies of oral neutrophil levels in patients receiving G-CSF after autologous marrow transplantation.

Lieschke GJ, Ramenghi U, O'Connor MP, Sheridan W, Szer J, Morstyn G. Lieschke GJ, et al. Br J Haematol. 1992 Nov;82(3):589-95. doi: 10.1111/j.1365-2141.1992.tb06472.x. Br J Haematol. 1992. PMID: 1283080

3

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1).

Lieschke GJ, Burgess AW. Lieschke GJ, et al. N Engl J Med. 1992 Jul 2;327(1):28-35. doi: 10.1056/NEJM199207023270106. N Engl J Med. 1992. PMID: 1375975 Review. No abstract available.

4

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2).

Lieschke GJ, Burgess AW. Lieschke GJ, et al. N Engl J Med. 1992 Jul 9;327(2):99-106. doi: 10.1056/NEJM199207093270207. N Engl J Med. 1992. PMID: 1376442 Review. No abstract available.

5

Clinical trials of granulocyte colony-stimulating factors for treatment of bone marrow depression associated with cancer chemotherapy.

Lieschke GJ, Morstyn G. Lieschke GJ, et al. Immunol Ser. 1992;57:671-93. Immunol Ser. 1992. PMID: 1380312 Review. No abstract available.

6

The dissociation of GM-CSF efficacy from toxicity according to route of administration: a pharmacodynamic study.

Cebon J, Lieschke GJ, Bury RW, Morstyn G. Cebon J, et al. Among authors: lieschke gj. Br J Haematol. 1992 Feb;80(2):144-50. doi: 10.1111/j.1365-2141.1992.tb08891.x. Br J Haematol. 1992. PMID: 1550769

7

Towards improved cancer therapy using subcutaneously administered hemopoietic colony stimulating factors.

Morstyn G, Sheridan W, Lieschke G, Cebon J, Layton J, Fox R. Morstyn G, et al. Prog Clin Biol Res. 1990;354B:29-36. Prog Clin Biol Res. 1990. PMID: 1700441 Review. No abstract available.

8

The effects of dose and route of administration on the pharmacokinetics of granulocyte-macrophage colony-stimulating factor.

Cebon JS, Bury RW, Lieschke GJ, Morstyn G. Cebon JS, et al. Among authors: lieschke gj. Eur J Cancer. 1990;26(10):1064-9. doi: 10.1016/0277-5379(90)90053-v. Eur J Cancer. 1990. PMID: 2148882 Clinical Trial.

9

Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.

Lieschke GJ, Maher D, O'Connor M, Green M, Sheridan W, Rallings M, Bonnem E, Burgess AW, McGrath K, Fox RM, et al. Lieschke GJ, et al. Cancer Res. 1990 Feb 1;50(3):606-14. Cancer Res. 1990. PMID: 2404573

10

Clinical experience with recombinant human granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor.

Morstyn G, Lieschke GJ, Sheridan W, Layton J, Cebon J, Fox RM. Morstyn G, et al. Among authors: lieschke gj. Semin Hematol. 1989 Apr;26(2 Suppl 2):9-13. Semin Hematol. 1989. PMID: 2471275 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters